Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AIM ImmunoTech (AIM) Depreciation and Depletion (2018 - 2025)

Historic Depreciation and Depletion for ImmunoTech (AIM) over the last 11 years, with Q3 2025 value amounting to $9000.0.

  • ImmunoTech's Depreciation and Depletion fell 1000.0% to $9000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $37000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $37000.0 for FY2024, which is 512.82% down from last year.
  • As of Q3 2025, ImmunoTech's Depreciation and Depletion stood at $9000.0, which was down 1000.0% from $9000.0 recorded in Q2 2025.
  • Over the past 5 years, ImmunoTech's Depreciation and Depletion peaked at $11000.0 during Q1 2023, and registered a low of $9000.0 during Q3 2023.
  • Its 3-year average for Depreciation and Depletion is $9454.5, with a median of $9000.0 in 2023.
  • Within the past 5 years, the most significant YoY rise in ImmunoTech's Depreciation and Depletion was 1111.11% (2024), while the steepest drop was 1818.18% (2024).
  • Quarter analysis of 3 years shows ImmunoTech's Depreciation and Depletion stood at $9000.0 in 2023, then changed by 0.0% to $9000.0 in 2024, then changed by 0.0% to $9000.0 in 2025.
  • Its Depreciation and Depletion was $9000.0 in Q3 2025, compared to $9000.0 in Q2 2025 and $10000.0 in Q1 2025.